about
Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cellsHistamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidaseVariants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3.Stronger T cell immunogenicity of ovalbumin expressed intracellularly in Gram-negative than in Gram-positive bacteria.Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia.NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemiaMutated NPM1 in combination with overexpression of Meis1 or Hoxa9 is not sufficient to induce acute myeloid leukemia.Streptococcus pneumoniae autolysis prevents phagocytosis and production of phagocyte-activating cytokines.Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosisIntact Pneumococci Trigger Transcription of Interferon-Related Genes in Human Monocytes, while Fragmented, Autolyzed Bacteria Subvert This Response.TLR-Stimulated Neutrophils Instruct NK Cells To Trigger Dendritic Cell Maturation and Promote Adaptive T Cell Responses.Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells.Pneumolysin released during Streptococcus pneumoniae autolysis is a potent activator of intracellular oxygen radical production in neutrophils.Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.Redox remodeling by dendritic cells protects antigen-specific T cells against oxidative stress.Role of NOX2-Derived Reactive Oxygen Species in NK Cell-Mediated Control of Murine Melanoma Metastasis.Soluble bacterial constituents down-regulate secretion of IL-12 in response to intact Gram-positive bacteria.Role of NOX2 for leukaemic expansion in a murine model of BCR-ABL1(+) leukaemia.NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.Chronic myeloid leukemic cells trigger poly(ADP-ribose) polymerase-dependent inactivation and cell death in lymphocytes.Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.Reply: To PMID 24519039.Redox control of cancer cell destruction.Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics.Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative diseaseHistamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockadeGram-Positive and Gram-Negative Bacteria Induce Different Patterns of Cytokine Production in Human Mononuclear Cells Irrespective of Taxonomic RelatednessCytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid LeukemiaIsolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma PatientsThe HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemiaAntitumor properties of histamine in vivoImmunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemiaMelphalan, Antimelanoma Immunity, and Inflammation--LetterIsolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis
P50
Q28256749-EE5DF9E1-90C6-4A3D-A45F-CCEA60F75F9EQ28392943-186908FE-CFEA-4492-AD22-1D66FB672A7AQ33413296-A0C3DECB-A688-444B-AD30-D028F255D297Q34761219-3B2637CF-8E8C-47A5-9F51-A1D7FC63A8ACQ35107809-AB08186C-4F5A-4D69-9BCA-0E2E0B5B4B53Q36597388-02A1B6B3-F787-41A1-B125-F8DBCE327880Q36618933-D72CE272-32AE-4CD1-B238-F8CBC6CC0D7EQ36718300-3240EAB6-3C5F-4699-A613-15B624C96BADQ36946572-939317DA-24CC-4C15-B8E5-04A155590E91Q37170146-F8F36217-9920-401B-800D-E86FC2C6C2C7Q37333399-A3B7C11D-72E4-43FB-918E-26CEB65276A4Q37362596-D2F95B8E-3E67-437E-8310-A66A3151EEE7Q38772230-882EB00B-C9F3-4B15-8229-B21A74498EBAQ39355305-78FF7FCE-B5D8-4CE1-9BA8-DAAF34CBAA9BQ40323128-70B47DB0-B8E7-4426-BE61-ABC0490E17C3Q40825087-6EA77C88-2923-4E08-9EFF-D9076FCDC046Q41527981-37E86AD5-E52C-4D4E-8241-ED3D0C3B4A25Q42406529-5845D92B-0952-4E94-BC1D-6867D7FEA7F1Q42683573-F4ABB4FF-8F44-4B01-9601-6F4911B6690FQ43628074-DDD8EBED-7AD4-4236-83F6-678CC04F369BQ46328173-18327D37-78EB-4026-A4AE-366DB9FA2CC0Q46334379-6215DD04-56A3-4872-BFB5-25C02213FB4CQ46361008-17BE9A63-DF36-42A2-8EAA-230FAEB72140Q46404275-D9C2D962-F468-4F92-94D4-B1C5ECFC56E3Q46904432-5CA27F78-D9DE-4F3E-B0D8-59DFBD503F5CQ48691891-DD157787-9628-4FE2-B933-3B9015D683B5Q50283920-1046D4F1-32B4-47C5-9318-BC864CBD324DQ51748168-A089C267-E370-4A5A-89C4-CDC5F73C754CQ54435126-0C1E5E89-FE39-4B27-B342-44DA1E23F0CDQ55397325-93C65F1A-5064-4DE5-8D55-249FA0AAEB6AQ57464994-80DBA890-F97D-4D9A-8E0F-6C2EA0A1F90CQ57470560-C0656799-B4E9-4A65-AB7C-AC9F9380D3DDQ58848608-001A8CE3-FA5A-4905-B203-9A8010929C38Q59638379-074F3BBC-1018-4371-81BB-E05762B31832Q60047604-2E55BA15-21B9-4E0A-91EB-E6FE19981351Q64105989-4B2DE3EB-ADF0-4A49-B302-238C84410F21Q84048414-F9848EE1-2254-49D8-A80B-1E65520833A8Q85639094-CB318832-B088-4760-99E0-DF67A16B7ED7Q86840372-C9E7ED68-35E3-4D2C-B097-DC29CD2CE58FQ89457603-4500E9B6-F759-4883-99EC-A44F02BBB7BF
P50
description
researcher ORCID ID = 0000-0002-6598-5221
@en
name
Anna Martner
@ast
Anna Martner
@en
Anna Martner
@es
Anna Martner
@nl
type
label
Anna Martner
@ast
Anna Martner
@en
Anna Martner
@es
Anna Martner
@nl
prefLabel
Anna Martner
@ast
Anna Martner
@en
Anna Martner
@es
Anna Martner
@nl
P21
P31
P496
0000-0002-6598-5221